Unknown

Dataset Information

0

Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.


ABSTRACT: MicroRNAs (miRNAs) are short noncoding RNAs that play critical roles in human malignancies and can be used as biomarkers for cancer. Until now, a number of biomarkers for prognosis of glioblastoma (GBM) have been reported in tumor tissues but only a few biomarkers in circulating fluid. Using a custom microarray, we previously identified 19 differentially expressed miRNAs in serum of patients with GBM. In this study, we investigated whether 3 of the 19 miRNAs in serum could be used as prognostic biomarkers for patients with GBM. We first validated the serum levels of 3 candidate miRNAs in an independent cohort of 24 GBM patients and 12 healthy volunteers by real-time quantitative reverse transcription PCR (qRT-PCR), and then evaluated the prognostic value of these miRNAs in a total of 36 GBM patients. The results show that the serum levels of the 3 miRNAs (miR-451a, miR-485-3p and miR-4298) determined by qRT-PCR are significantly different between 24 GBM patients and 12 healthy volunteers (all P <0.05) and are in concordance with the results of microarray analysis. High serum level of miR-451a is correlated with positive tumor O(6)-methylguanine-DNA methyltransferase (MGMT) expression (P = 0.040). Survival analysis showed that low serum miR-485-3p level is associated with poor progression-free survival (PFS) (P < 0.004) and overall survival (OS) (P < 0.023). Furthermore, univariate and multivariate Cox analyses demonstrated that that serum miR-485-3p expression is a significant independent prognostic factor for PFS and OS in GBM patients. In conclusion, serum miR-485-3p level is reduced and might be a potential prognostic biomarker in GBM patients.

SUBMITTER: Wang ZQ 

PROVIDER: S-EPMC5607158 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.

Wang Zhi-Qiang ZQ   Zhang Mei-Yin MY   Deng Mei-Ling ML   Weng Nuo-Qing NQ   Wang Hui-Yun HY   Wu Shao-Xiong SX  

PloS one 20170920 9


MicroRNAs (miRNAs) are short noncoding RNAs that play critical roles in human malignancies and can be used as biomarkers for cancer. Until now, a number of biomarkers for prognosis of glioblastoma (GBM) have been reported in tumor tissues but only a few biomarkers in circulating fluid. Using a custom microarray, we previously identified 19 differentially expressed miRNAs in serum of patients with GBM. In this study, we investigated whether 3 of the 19 miRNAs in serum could be used as prognostic  ...[more]

Similar Datasets

2017-11-01 | GSE93850 | GEO
| S-EPMC4823935 | biostudies-literature
| S-EPMC3751825 | biostudies-literature
| S-EPMC6143616 | biostudies-literature
| S-EPMC8457601 | biostudies-literature
| S-EPMC6528889 | biostudies-literature
| S-EPMC7988701 | biostudies-literature
| S-EPMC10826677 | biostudies-literature
| S-EPMC3616902 | biostudies-literature
| S-EPMC10329125 | biostudies-literature